▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4069 by analyst upside · 2026-08-14
CNMD
CONMED Corporation
Healthcare · Market Cap $1B · P/E 26.9x
ANALYST PRICE TARGET
-8.7%
implied upside to consensus target
Current Price $49.82
Consensus Target $45.5
Bull Target $49.0
Bear Target $43.0
Analysts Covering 6
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
0
Hold
5
Sell
1
52-Week Low $31.44
52-Week High $56.64
YTD Return +23.0%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 26.9x
Forward P/E 10.4x
EPS (TTM) $1.85
PEG Ratio 1.84
Dividend Yield 1.62%
Revenue (TTM) $1.4B
Profit Margin 4.1%
52-WEEK RANGE
52-Week Low $31.44
52-Week High $56.64
Current Price $49.82
Bear Target $43.0
Bull Target $49.0
● Now $49.82 ● Target $45.5
TRADING DATA
Avg Volume 633K
YTD Return +23.0%
Analyst Count 6
Consensus Hold
Upside to Target -8.7%
Last Updated 2026-08-14

ANALYST SUMMARY

CONMED Corporation (CNMD) is currently trading at $49.82 with a Wall Street consensus price target of $45.5, which is 8.7% below the current price over the next 12 months. 6 analysts currently cover CNMD, with a consensus rating of Hold - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $49.0, while the most cautious has a target of $43.0.

CNMD operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 23.0% year-to-date and is currently trading near the upper end of its 52-week range of $31.44 – $56.64.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

AMN +1.5%
AMN Healthcare Services, Inc.
$1B · P/E 12.8x · Buy
PNTG +19.9%
The Pennant Group, Inc.
$1B · P/E 42.5x · Buy
BVS +21.0%
Bioventus Inc.
$1B · P/E 17.8x · Buy
HCSG +27.1%
Healthcare Services Group, Inc.
$1B · P/E 12.3x · Hold
PAHC +32.1%
Phibro Animal Health Corporation
$1B · P/E 14.6x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for CNMD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

B of A Securities - Reiterated
Neutral → Neutral 2026-05-18 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-05-01 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2026-04-30 43% win rate (7 calls)
Piper Sandler ↓ Downgrade
Overweight → Neutral 2026-03-17 14% win rate (7 calls)
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-01-29 Building track record
Needham reit
Hold → Hold 2026-01-29 20% win rate (5 calls)
B of A Securities - Reiterated
Neutral → Neutral 2025-12-08 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2025-11-06 43% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
45
out of 100
Coverage depth
15/30
Consensus clarity
28/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →